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Levonorgestrel intrauterine system
embedded within tubal ectopic pregnancy:
a case report
Dorothy Makena* , Ingrid Gichere and Khadija Warfa

Abstract
Background: The presence of the levonorgestrel-releasing intrauterine system embedded within an ectopic pregnancy is a rare occurrence. Tubal migration of an intrauterine device is not well understood and has not been extensively studied in literature.
Case presentation: A 34-year-old African woman, para 1, gravida 2, presented with symptoms of ruptured ectopic
pregnancy. She underwent a laparoscopy where a ruptured left ectopic pregnancy was found with a levonorgestrelreleasing intrauterine system inserted 2 years prior embedded within the tube. A left salpingectomy was performed
with removal of the levonorgestrel-releasing intrauterine system. The patient recovered well and proceeded to have
an intrauterine pregnancy 3 months later.
Conclusion: Migration of the levonorgestrel-releasing intrauterine system into the fallopian tube is a rare occurrence
that is not well understood. In the case presented, levonorgestrel-releasing intrauterine system was found embedded
within the fimbrial end of the left fallopian tube, which had a ruptured ectopic pregnancy. Surgical treatment with
laparoscopy is recommended for intraabdominal intrauterine device to prevent complications.
Keywords: IUD, Mirena, Levonorgestrel IUS, Ectopic pregnancy, Tubal migration
Background
An intrauterine contraceptive device (IUD) is a highly
effective method of contraception [1]. Types of IUDs
include the levonorgestrel releasing intrauterine system
(LNG IUS), also commonly referred to as Mirena, and
the copper IUD. They have a low failure rate of less than
1%, which is comparable to permanent sterilization [1].
The pearl index of the LNG IUS is 0.06 per 100 women
years, while that of the copper IUD is 0.52 per 100
women years [2]. Even though the risk of ectopic pregnancy with IUDs is lower than with no contraception,
if a pregnancy occurs with an IUD in situ, it is likely to
be an ectopic pregnancy. The rate of ectopic pregnancy
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among LNG IUS users ranges from 0.02 to 0.2 per 100
women years, whereas the rate among copper IUD users
ranges from 0.1 to 0.8 per 100 women years. In case of
pregnancy, the risk of ectopic pregnancy is higher in
LNG IUS users compared with copper IUD users (27%
versus 15% respectively) [2]. Progesterone is known to
cause ciliary dysfunction within the fallopian tube, subsequently predisposing LNG IUS users who conceive to
ectopic pregnancy [3]. It is therefore important to rule
out ectopic pregnancy in women with acute abdomen or
positive pregnancy test among LNG IUS users [4]
A correctly positioned IUD is located within 3 mm
of the uterine fundus, with both arms extending to the
cornua, a vertically oriented stem in the uterine body,
and the strings protruding through the cervical os into
the vaginal canal [5]. Suboptimally placed IUDs are at a
higher risk of malposition or expulsion and associated
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symptoms [5]. Malposition of IUDs is a common complication of this method of contraception, with a reported
rate of up to 10% [6]. Malposition of an IUD includes
displacement, expulsion, rotation, or embedment. Migration of IUDs is, however, an uncommon occurrence,
with most cases of migration reported to the colon and
the urinary tract [7–9]. The fallopian tube is an uncommon location for migration and embedment [7]. Having
an IUD embedded within a tubal ectopic pregnancy is an
even rarer phenomenon.
We describe a case of a patient who presented with
ruptured ectopic pregnancy and was found to have a
LNG IUS embedded in the fimbrial end of the affected
fallopian tube.

Case presentation
A 34-year-old African female, para 1, gravida 2, presented
to the Accident and Emergency Department, having had
symptoms of vomiting and abdominal pain for 3 days.
The symptoms had worsened on the day of presentation
to the hospital. She reported several episodes of vomiting
with associated loose stools and abdominal fullness. She
also had ongoing vaginal bleeding that had started 5 days
prior to presentation.
Two years prior, the patient had an uncomplicated
insertion of LNG IUS by an obstetrician/gynecologist at
the 8-week visit following a normal vaginal delivery. She
had a normal pap smear done at the time of insertion.
One year following insertion, she had a desire to conceive
and was scheduled for removal of the LNG IUS device.
The strings could not be seen, and the device could not
be retrieved with alligator forceps. The patient was therefore sent for a pelvic ultrasound to locate the lost IUD.
The device was not seen on ultrasound. The patient was,
however, lost to follow-up until presentation with symptoms of ruptured ectopic pregnancy. She had no preexisting conditions or previous surgery.
On physical examination she was in fair general condition and not pale. Her vital signs were a temperature of
37.6 °C, a blood pressure of 120/66 mmHg, pulse rate of
99 beats per minute, respiration rate of 18 breaths per
minute, and oxygen saturation of 100% on room air. On
abdominal examination she had tenderness on the left
iliac fossa and suprapubic regions with absent bowel
sounds. The rest of the systemic examination was normal. An impression of acute abdomen was made at this
point. As initial treatment she was given intravenous
fluids (Ringer’s lactate solution) 1-L bolus, as well as
intravenous paracetamol and ondansetron for pain and
vomiting, respectively.
The initial investigations included a full blood count,
which revealed a normal hemoglobin level of 13.2 g/dl,
slightly elevated white cell count of 12.28 × 109 cells/L,
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and normal platelet count of 314 × 109 cells/L. She had a
beta human chorionic gonadotropin (Hcg) level of 7721
mIU/ml. Urinalysis showed leucocytes 2+, nitrite negative, and blood 2+. Transvaginal ultrasound showed a
2.1 cm × 1.8 cm echogenic mass with central cystic area
on the left adnexa. It had no internal or peripheral vascularity. There was marked pelvic echogenic free fluid with
low internal echoes extending to the Morrison’s pouch.
The uterus was anteverted and normal in size and shape
with an endometrial thickness of 5.5 mm. A 1.9 cm cystic
lesion was seen in the right ovary, which was likely a corpus luteum cyst. There was no gestational sac or intrauterine device seen within the endometrial cavity (Fig. 1).
These features indicated ruptured ectopic pregnancy.
The diagnosis at this point was a ruptured left tubal
ectopic pregnancy. The plan was to admit the patient for
an emergency laparoscopy with possible left salpingectomy. The diagnosis and plan were explained to the
patient, who signed an informed consent for the procedure. Group and cross match of one unit of packed red
cells was ordered in case a transfusion would be required.
The laparoscopy was done under general anesthesia
in the Lloyd–Davis position. Cohen’s uterine manipulator was placed. Veress insufflation was performed, followed by insertion of a 10-mm primary trocar at the
umbilicus. Entry and operating pressures were 20 mmHg
and 15 mmHg, respectively. Two secondary ports were
inserted under vision, 5 mm in the right iliac fossa and
12 mm in the left iliac fossa. On primary survey, LNG
IUS was found embedded at the fimbrial end of the left
fallopian tube (Fig. 2). The LNG IUS was retrieved whole
under vision through the 12-mm port (Fig. 3). There was
hemoperitoneum of 700 ml (Fig. 2). A ruptured left ampullary ectopic pregnancy was identified by left salpingectomy using bipolar coagulation and scissors (Fig. 4). A
corpus luteum cyst was found on the right ovary with
normal right fallopian tube. Suction and peritoneal lavage were performed, and hemostasis was confirmed
(Fig. 5). The specimen was retrieved through the 12-mm
port and taken for histology. There was no sign of uterus
perforation. The pouch of Douglas and rectum appeared
normal. All trocars were removed under vision.
The postoperative recovery of the patient was unremarkable. She was debriefed about the surgery and discharged the following morning. She went home on oral
paracetamol and diclofenac for pain relief.
The patient was reviewed in the gynecology outpatient
clinic 2 weeks later. She was asymptomatic and doing
well. Histology report confirmed left ectopic tubal gestation. She reported that she desired conception. Preconception counseling was done. She was put on daily folic
acid (400 µg). The patient was advised to come to the hospital as soon as she missed a period or tested positive for
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Fig. 1 Ultrasound image of an empty uterus. The arrow points to the endometrial lining measuring 5.5 mm

Fig. 2 Body of the embedded LNG IUS (indicated by arrow), which is seen protruding from the left tubal pregnancy with hemoperitoneum

pregnancy for an early pregnancy ultrasound to rule out
another ectopic pregnancy. Three months later she presented at the early pregnancy clinic following 5 weeks of
amenorrhea. A pelvic ultrasound was done that showed
intrauterine pregnancy at 5 weeks gestation.

Discussion
The above case documents a rare occurrence of a ruptured ectopic pregnancy with the LNG IUS embedded
within the affected fallopian tube.

Levonorgestrel IUS (Mirena) is a safe, reversible, and
highly effective contraceptive method [2]. It is known
to have other therapeutic benefits such as reduction in
menstrual bleeding, anemia, and dysmenorrhea, as well
as management of endometrial hyperplasia [10]. In this
patient, the use of the LNG IUS was purely for contraception purposes.
Ectopic pregnancies affect approximately 2% of all
pregnancies. The most common presentation of an
ectopic pregnancy is abdominal pain and abnormal
uterine bleeding [11]. Even though the rate of ectopic
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Fig. 3 LNG IUS (indicated by arrow) being retrieved from the left tubal pregnancy

Fig. 4 Left salpingectomy (indicated by arrow) performed using bipolar coagulation

pregnancy is lower in women using LNG IUS, if a pregnancy occurs while using this IUD, there is a high risk
of it being an ectopic pregnancy [2]. Current IUD use is
a known risk factor for ectopic pregnancy [12]. Other
risk factors for ectopic pregnancy include pelvic inflammatory disease, previous tubal surgery, previous ectopic
pregnancy, and smoking [12]. On examination, features
of acute abdomen due to hemoperitoneum may be present [11, 12]. The patient in this case had a presentation suggestive of ectopic pregnancy with concurrent
LNG IUS use as a risk factor. However, she had other

unspecific presenting features of diarrhea, vomiting, and
low-grade fever. It is important to note that some patients
may be asymptomatic without specific risk factors for an
ectopic pregnancy [12]
On the other hand, malposition of an IUD is one of its
common complications, presenting with pelvic pain and
bleeding or no symptoms [13]. Although malposition is
associated with reduced contraceptive efficacy, this is
mostly true for copper IUDs and not LNG IUS, which has
local progesterone effects [6]. Malposition is diagnosed
by ultrasound [13]. However, compared with copper
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Fig. 5 Pelvic view after completion of the procedure confirming hemostasis. Arrow points to an empty pouch of Douglas

IUDs, the LNG IUS is more likely to be missed by ultrasonography. LNG IUS is compounded with barium sulfate, which makes it radio opaque for X-ray recognition
[14]. A plain X-ray can therefore be used as an adjunctive
imaging modality in the case of a lost LNG IUS not seen
on ultrasound [15]. The patient in this case had a lost
LNG IUS not seen on ultrasound 1 year after insertion
but was lost to follow-up for additional imaging.
Uterine perforation is uncommon, with an incidence of
1 in 1000 insertions. It is a serious complication of IUD
use and is often asymptomatic [16]. There is increased
risk of perforation if insertion is done less than 6 months
postpartum or while breastfeeding. This period is associated with endometrial atrophy with accelerated uterine
involution and hence has a high risk of perforation [6,
13]. The current patient was asymptomatic for malposition or perforation for 2 years prior to the ectopic pregnancy. The transvaginal ultrasound done at diagnosis of
ectopic pregnancy did not visualize the device in the left
adnexa. Her LNG IUS was inserted only 2 months postpartum while breastfeeding. This may have been a risk
factor for possible unrecognized perforation.
Routine transvaginal ultrasound to monitor IUD position either immediately post insertion or after 6 weeks
is not recommended without clinical suspicion of malposition according to de Kroon et al. [17]. It has been
reported that IUDs take approximately 3 months to settle into their stable position. An initially malpositioned
IUD can therefore assume the correct fundal position
over time [18]. In asymptomatic women with uncomplicated IUD insertion, routine ultrasound lacks benefit over clinical evaluation with string check at 6 weeks

[17]. The patient in this case was asymptomatic without
complications at insertion. One year later, the LNG IUS
device could not be seen on clinical examination nor on
ultrasound.
The mechanism of device migration is not well understood, especially in the case of tubal migration. The fallopian tube is a rare site for dislocated IUD [19, 20]. This
phenomenon has been described in few case reports.
There are theories from case reports about the tubal
migration of an IUD. The first possibility is placement
of the device at the tubal ostium during insertion with
subsequent migration into the tube due to uterine contractions and tubal peristalsis [21]. The other possibility
is uterine perforation with migration of the device into
the peritoneal cavity and subsequent perforation of a preexisting hydrosalpinx as described by Ozdemir et al. in
a case report [19]. The patient in this case did not have
any hydrosalpinx noted intraoperatively. Perforation
can be due to either immediate traumatic perforation at
insertion or delayed transmural migration [22, 23]. It is
also possible that, following an unrecognized perforation, there was nestling of the IUD close to the fimbrial
end of the fallopian tube, with the device being enveloped within the fimbria [7, 19]. This phenomenon could
have occurred antecedent to conception of the ectopic
pregnancy. In the patient in this case, there was no sign
of uterus perforation. The pouch of Douglas and rectum
appeared normal.
The presence of an IUD within the fallopian tube is
associated with an inflammatory reaction [19] interfering with tubal function and predisposing the patient to
ectopic pregnancy. The tubal dysfunction is exacerbated

Makena et al. J Med Case Reports

(2021) 15:107

by progesterone in the LNG IUS, which interferes with
ciliary beating and tubal contractility [3]. It is possible
that the embedment of LNG IUS at the fimbrial end of the
fallopian tube occurred as a result of displacement from
the proximal tube by the growing tubal pregnancy or its
rupture.
Once an intraabdominal IUD is diagnosed, it should
be removed whether it is symptomatic or not to avoid
serious complications such as adhesion formation,
bowel obstruction, and infertility [15, 19]. Laparoscopy
is the surgical approach of choice as it is safe and effective. It provides good visualization to locate and remove
a lost IUD [15]. In this case, the diagnosis of the LNG
IUS within the fallopian tube and its removal were done
laparoscopically.

Conclusion
Migration of the LNG IUS into the fallopian tube is a
rare occurrence that is not well understood. In the case
presented, a LNG IUS was found embedded within the
fimbrial end of the fallopian tube that had a ruptured
ectopic pregnancy. Surgical treatment with laparoscopy
is recommended for intraabdominal IUD to prevent
complications. The patient made a good recovery and
proceeded to have an intrauterine pregnancy 3 months
later, as desired.
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